New C‐indices for assessing importance of longitudinal biomarkers in fitting competing risks survival data in the presence of partially masked causes
Md. Tuhin Sheikh(University of Connecticut), Joseph G. Ibrahim(University of North Carolina at Chapel Hill), Jonathan Gelfond(The University of Texas at San Antonio Health Science Center), Wei Sun(Fred Hutch Cancer Center), Ming‐Hui Chen(University of British Columbia)
Cited by 4
Related Papers
Genetic Mechanisms of Immune Evasion in Colorectal Cancer
|Cancer Discovery|2018|558
Use of historical control data for assessing treatment effects in clinical trials
|Pharmaceutical Statistics|2013|505
Senolytics dasatinib and quercetin in idiopathic pulmonary fibrosis: results of a phase I, single-blind, single-center, randomized, placebo-controlled pilot trial on feasibility and tolerability
|EBioMedicine|2023|275
Metabolic Biosynthesis Pathways Identified from Fecal Microbiome Associated with Prostate Cancer
|European Urology|2018|224
Strain-Dependent Variation in 18S Ribosomal DNA Copy Numbers in <i>Aspergillus fumigatus</i>
|Journal of Clinical Microbiology|2009|197